Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

Autor: Luque Paz, Damien ^**, Riou, Jérémie, Verger, Emmanuelle, Cassinat, Bruno, Chauveau, Aurélie, Ianotto, Jean-Christophe, Dupriez, Brigitte, Boyer, Françoise, Renard, Maxime, Mansier, Olivier, Murati, Anne, Rey, Jérôme, Etienne, Gabriel, Mansat-De Mas, Véronique, Tavitian, Suzanne, Nibourel, Olivier, Girault, Stéphane, Le Bris, Yannick, Girodon, François, Ranta, Dana, Chomel, Jean-Claude, Cony-Makhoul, Pascale, Sujobert, Pierre, Robles, Margot, Ben Abdelali, Raouf, Kosmider, Olivier, Cottin, Laurane, Roy, Lydia, Sloma, Ivan, Vacheret, Fabienne, Wemeau, Mathieu, Mossuz, Pascal, Slama, Borhane, Cussac, Vincent, Denis, Guillaume, Walter-Petrich, Anouk, Burroni, Barbara, Jézéquel, Nathalie, Giraudier, Stéphane, Lippert, Eric, Socié, Gérard, Kiladjian, Jean-Jacques, Ugo, Valérie ^*

Publikováno v: In Blood Advances 9 March 2021 5(5):1442-1451

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients

Autor: Bou Samra, Elias, Moreaux, Jérôme, Vacheret, Fabienne, Mills, Ken, Rufflé, Florence, Chiesa, Jean, Piquemal, David, Boureux, Anthony, Lavabre-Bertrand, Thierry, Jourdan, Eric, Commes, Thérèse

Publikováno v: British Journal of Haematology
British Journal of Haematology, Wiley, 2012, 157 (3), pp.347-56. ⟨10.1111/j.1365-2141.2012.09069.x⟩

International audience; Chronic myelomonocytic leukaemia (CMML) is a heterogeneous haematopoietic disorder characterized by myeloproliferative or myelodysplastic features. At present, the pathogenesis of this malignancy is not completely understood.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::41480f7bfed09648aeb502070af44508
https://www.hal.inserm.fr/inserm-00681007/file/Prognostic_markers_in_CMML_Bou_Samra_et_al_BJH_2012.pdf

New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.

Autor: Bou Samra E; Groupe d'études des transcriptomes, Université Montpellier 2, Centre de Recherche en Biochimie Macromoléculaire, Montpellier, France., Moreaux J, Vacheret F, Mills K, Rufflé F, Chiesa J, Piquemal D, Boureux A, Lavabre-Bertrand T, Jourdan E, Commes T

Publikováno v: British journal of haematology [Br J Haematol] 2012 May; Vol. 157 (3), pp. 347-56. Date of Electronic Publication: 2012 Mar 06.